San Francisco, 12 December 2018, Biopharmaceuticals Contract Manufacturing
Market Analysis Report By Source, By Service (Process Development, Analytical
& QC Studies), By Product (Biologics, Biosimilars), And Segment Forecasts,
2018 – 2025
The global biopharmaceuticals contract manufacturing market size
is expected to reach USD 21.7 billion by 2025, according to a new report by
Grand View Research, Inc., registering a CAGR of 7.5% during the forecast
period. Growing biopharmaceutical pipeline and lack of adequate manufacturing
capabilities are two key factors driving partnerships between large molecule
manufacturers and contract manufacturing organizations (CMOs). Contract
manufacturers are engaged in broadening their service portfolio to meet
companies’ demand with respect to regulatory standards and new services.
Reliance of companies on CMOs
for production of biologics and biosimilars is expected to rise over the
forecast period as a consequence of changes adopted by CMOs. This is evident
through growing investments in collaborations of companies with CMOs as well as
continuous efforts taken up for broadening service portfolios.
The growth of CMOs is highly
dependent on promising opportunities offered by the biopharmaceutical industry,
bioprocessing industry, and contract service industry. Expansion of
fill-and-finish services and increasing robustness of venture capital
investments in the life science sector are important opportunities that are
anticipated to drive the market.
Access Full Research
Report On Biopharmaceuticals Contract
Manufacturing Market Analysis:
www.grandviewresearch.com/industry-analysis/biopharmaceuticals-contract-manufacturing-market
www.grandviewresearch.com/industry-analysis/biopharmaceuticals-contract-manufacturing-market
Further key findings from the report suggest:
·
Based on source,
mammalian-based biopharmaceutical contract manufacturing captured the largest
market share owing to high penetration of mammalian expression systems for
biologics development
·
By service, upstream and
downstream services accounted for the largest revenue share. Complexities
associated with these steps pronounces demand for established contract
manufacturers to ensure manufacturing processes compliant with regulatory
standards
·
Biologics contract
manufacturing dominated the market based on product owing to higher demand for
biologics production. However, the biosimilar segment is slated to exhibit a
lucrative CAGR due to cost-saving advantages associated with its development
·
Presence of effective
regulatory framework for biologics development in U.S. has resulted in North
America market accounting for the dominant share in 2017. However, Asia Pacific
is expected to emerge as the fastest growing regional market, with developing
economies expanding at a substantial pace and incorporating developments to
sustain the competition
·
Several international companies
are seeking outsourcing of biopharmaceutical production to Asian countries
owing to continuous expansion of Asian CMOs that offer services at a reduced
price, compared to service providers based in western countries
·
Some of the key service
providers are Boehringer Ingelheim GmbH; Lonza; Samsung BioLogics; and FUJIFILM
Diosynth Biotechnologies U.S.A., Inc.
Browse More Reports Of This Category By
Grand View Research At: www.grandviewresearch.com/industry/biotechnology
Grand View Research has segmented the
global biopharmaceuticals contract manufacturing market on the basis of source,
service, product, and region:
Biopharmaceuticals Contract
Manufacturing Source Outlook (Revenue, USD Million, 2014 - 2025)
·
Mammalian
·
Non-mammalian
Biopharmaceuticals Contract
Manufacturing Service Outlook (Revenue, USD Million, 2014 - 2025)
·
Process Development
o
Downstream
o
Upstream
·
Fill & Finish Operations
·
Analytical & QC Studies
·
Packaging
Biopharmaceuticals Contract
Manufacturing Product Outlook (Revenue, USD Million, 2014 - 2025)
·
Biologics
o
Monoclonal Antibodies (MAbs)
o
Recombinant Proteins
o
Vaccines
o
Antisense, RNAi, &
Molecular Therapy
o
Others
·
Biosimilars
Biopharmaceuticals Contract
Manufacturing Regional Outlook (Revenue, USD Million, 2014 - 2025)
·
North America
o
U.S.
o
Canada
·
Europe
o
Germany
o
France
·
Asia Pacific
o
China
o
India
·
Latin America
o
Brazil
·
Middle East & Africa
o South Africa
Access Full Press Release of this Report:
www.grandviewresearch.com/press-release/global-biopharmaceuticals-contract-manufacturing-market
www.grandviewresearch.com/press-release/global-biopharmaceuticals-contract-manufacturing-market
About Grand View Research
Grand View Research, Inc. is a U.S. based market research and
consulting company, registered in the State of California and headquartered in
San Francisco. The company provides syndicated research reports, customized
research reports, and consulting services. To help clients make informed
business decisions, we offer market intelligence studies ensuring relevant and
fact-based research across a range of industries, from technology to chemicals,
materials and healthcare.
For more information: www.grandviewresearch.com/
